Skip to main content
Fig. 6 | Molecular Medicine

Fig. 6

From: Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5

Fig. 6

The schematic model of relationships between CASC2 regulating miR-532-3p/PAPD5 in the pathogenesis of atherosclerosis (AS). In the model of VSMC treated with ox-LDL, lncRNA CASC2 could compete with miR-532-3p by regulating PAPD5 participate in the proliferation and migration of VSMC, which suggest its critical roles in the pathogenesis of AS

Back to article page

Molecular Medicine

ISSN: 1528-3658